secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001708599-25-000065
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics sets 2025 annual meeting for Nov 7; updates proposal deadlines
--------------------------------------------------------------------------------

- Annual meeting scheduled for November 7, 2025; location and time in proxy.
- Rule 14a-8 stockholder proposals must be received by August 15, 2025.
- Director nominations and other proposals due August 9, 2025; earliest July 10.
- Meeting date change of >30 days from 2024 anniversary triggers adjusted deadlines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000065/0001708599-25-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000065/ser-20250701.htm
  HTML page:      https://secwatch.observer/filing/0001708599-25-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer